Impact of Smoking in Response to Tumor Necrosis Factor Inhibitors in Axial Spondyloarthritis: Methodologic Considerations for Longitudinal Observational Studies-Reference-Cited by-同舟云学术

Impact of Smoking in Response to Tumor Necrosis Factor Inhibitors in Axial Spondyloarthritis: Methodologic Considerations for Longitudinal Observational Studies

Published:2020-03-12 Issue:4 Volume:72 Page:591-599
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care Res

Author:

Zhao Sizheng Steven¹^ORCID,Yoshida Kazuki²,Jones Gareth T.³,Hughes David M.⁴,Tedeschi Sara K.⁵,Lyu Houchen⁶,Moots Robert J.⁷,Solomon Daniel H.⁸,Goodson Nicola J.⁷^ORCID

Affiliation:

1. University of Liverpool and Aintree University Hospital, Liverpool, UK, and Brigham and Women’s Hospital Boston Massachusetts

2. Brigham and Women’s Hospital and Harvard T. H. Chan School of Public Health Boston Massachusetts

3. University of Aberdeen Aberdeen UK

4. University of Liverpool Liverpool UK

5. Brigham and Women’s Hospital Boston Massachusetts

6. Harvard Medical School, Boston, Massachusetts, and General Hospital of Chinese PLA Beijing China

7. University of Liverpool and Aintree University Hospital Liverpool UK

8. Brigham and Women’s Hospital and Harvard Medical School Boston Massachusetts

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.23851

Reference32 articles.

1. Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics Register

2. Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registry

3. Smoking did not modify the effects of anti-TNF treatment on health-related quality of life among Australian ankylosing spondylitis patients

4. Smoking is not associated with response to TNF blockers in patients with axial spondyloarthritis;Dellyes A;Arthritis Rheumatol,2014

5. THU0359 Smoking was not Associated with Response to Adalimumab Therapy in Patients with Non-Radiographic Axial Spondyloarthritis

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Classification and management strategies for paediatric chronic nonbacterial osteomyelitis and chronic recurrent multifocal osteomyelitis;Expert Review of Clinical Immunology;2023-06-07

2. The impact of smoking on response to tumor necrosis factor-α inhibitor treatment in patients with ankylosing spondylitis;Turkish Journal of Medical Sciences;2023-01-01

3. EFFECTS OF SMOKING IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS RECEIVING TUMOR NECROSIS FACTOR INHIBITORS THERAPY;Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi;2022-05-16

4. Advances in treatment of axial spondyloarthritis are associated with improved patient outcomes: data from the Ankylosing Spondylitis Registry of Ireland (ASRI);Rheumatology International;2022-01-28

5. Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis;Rheumatology and Therapy;2021-12-28